InsiderTrades

Form 4 for INSP Inspire Medical Systems, Inc.

Accepted 2024-12-23 00:00:00 ET · period of report 2024-12-20 · accession 0001104659-24-131302 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2024-12-23 2024-12-20 INSP Herbert Timothy P. CEO, Pres, Dir J - Other — -61.8K 117.7K -34% —
DMI 2024-12-23 2024-12-20 INSP Herbert Timothy P. CEO, Pres, Dir J - Other — -72.7K 51.9K -58% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-12-20 J D 61,770 — 117,658 I By LLC — — (F1) Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions. (F2) Securities held by TPH 2022 LLC. Subsequent to the transactions reported herein, the Reporting Person is no longer considered the beneficial owner of securities held by TPH 2022 LLC and will no longer report securities held by TPH 2022 LLC on its subsequent reports.
2 Derivative Stock Option (Right to Buy) 2024-12-20 J D 28,840 — 54,934 I By LLC $71.00 · — to 2029-12-16 28,840 Common Stock (F1) Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions. (F2) Securities held by TPH 2022 LLC. Subsequent to the transactions reported herein, the Reporting Person is no longer considered the beneficial owner of securities held by TPH 2022 LLC and will no longer report securities held by TPH 2022 LLC on its subsequent reports. (F4) The option is fully vested and exercisable.
3 Derivative Stock Option (Right to Buy) 2024-12-20 J D 13,703 — 26,100 I By LLC $194.82 · — to 2030-12-14 13,703 Common Stock (F1) Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions. (F2) Securities held by TPH 2022 LLC. Subsequent to the transactions reported herein, the Reporting Person is no longer considered the beneficial owner of securities held by TPH 2022 LLC and will no longer report securities held by TPH 2022 LLC on its subsequent reports. (F4) The option is fully vested and exercisable.
4 Derivative Stock Option (Right to Buy) 2024-12-20 J D 2,915 — 5,553 I By LLC $227.53 · — to 2030-12-14 2,915 Common Stock (F1) Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions. (F2) Securities held by TPH 2022 LLC. Subsequent to the transactions reported herein, the Reporting Person is no longer considered the beneficial owner of securities held by TPH 2022 LLC and will no longer report securities held by TPH 2022 LLC on its subsequent reports. (F5) The original grant of options to purchase 17,773 shares of common stock vested and became exercisable as to 25% of the underlying shares on the first anniversary of February 11, 2022 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
5 Derivative Stock Option (Right to Buy) 2024-12-20 J D 27,254 — 51,913 I By LLC $42.15 · — to 2028-12-18 27,254 Common Stock (F1) Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions. (F2) Securities held by TPH 2022 LLC. Subsequent to the transactions reported herein, the Reporting Person is no longer considered the beneficial owner of securities held by TPH 2022 LLC and will no longer report securities held by TPH 2022 LLC on its subsequent reports. (F4) The option is fully vested and exercisable.